[1] Slevin, M.L., Stubbs, L., Plant, H.J., Wilson, P., Gregory, W.M., Armes, P.J., and Downer S.M. (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. British Medical Journal, 300, 1458-60.

[2] American Society of Clinical Oncology Health Services Research Committee. (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. Journal of Clinical Oncology, 14, 671-9.

[3] Schumacher, M., Olschewski, M., and Schulgen, G. (1991) Assessment of quality of life in clinical trials. Statistics in Medicine, 10, 1915-30.

[4] World Health Organization. (1948) Constitution of the World Health Organization. Geneva, Switzerland: WHO Basic Documents.

[5] Calman, K.C. (1984) Quality of life in cancer patients - an hypothesis. Journal of Medical Ethics, 10, 124-7.

[6] Thompson, J.A., and Fefer, A. (1987) Interferon in the treatment of hairy cell leukemia. Cancer, 59 (suppl 3), 605-9.

[7] Herndon, J.E., Fleishman, S., Kosty, M.P., and Green, A.R. (1997) A longitudinal study of quality of life in advanced non-small cell lung cancer: CALGB 8931. Controlled Clinical Trials, 18, 286-300.

[8] Saunders, C.M., and Fallowfield, L.J. (1996) Survey of the attitudes to and use of quality of life measures by breast cancer specialists in the UK. The Breast, 5, 425-6.

[9] Coates, A., Gebski, V., Bishop, J.F., Jeal, P.N., Woods, R.L., Synder, R., Tattersall, M.H.N., Byrne,M., Harvey, V., Gill, G., Simpson, J., Drummond, R., Browne, J., van Cooten, R., andForbes, J.F. (1987) Improving the quality of life during chemotherapy for advanced breast cancer. New England Journal of Medicine, 317, 1490-5.

[10] Tannock, I.F., Boyd, N.F., DeBoer, G., Erlichman, C., Fine, S., Larocque, G., Mayers, C., Perrault, D., and Sutherland, H. (1988) A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. Journal of Clinical Oncology, 6, 1377-87.

[11] Earl, H.M., Rudd, R.M., Spiro, S.G., Ash, C.M., James, L.E., Law, C.S., Tobias, J.S., Harper, P.G., Geddes, D.M., Eraut, D., Partridge, M.R., and Souhami, R.L. (1991) A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer, 64, 566-72.

[12] Medical Research Council Lung Cancer Working Party. (1989) Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Respiratory Medicine, 83, 51-8.

[13] Osoba, D. (1994) Lessons learned from measuring health-related Quality of Life in oncology. Journal of Clinical Oncology, 12, 608-16.

[14] Geddes, D.M., Dones, L., Hill, E., Law, K., Harper, P.G., Spiro, S.G., Tobias, J.F., andSouhami, R.L. (1990) Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. European Journal of Cancer, 26, 484-92.

[15] Stephens, R.J., Hopwood, P., Girling, D.J., and Machin, D. (1997) Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Quality of Life Research, 6, 225-36.

[16] Sneeuw, K.C.A., Aaronson, N.K., Sprangers, M.A.G., Detmar, S.B., Wever, L.D.V., and Schornagel, J.H. (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the Quality of Life of cancer patients. Journal of Clinical Epidemiology, 51, 617-31.

[17] Sprangers, M.A.G., and Aaronson, N.K. (1992) The role of health care providers and significant others in evaluating the Quality of Life of patients with chronic disease: a review. Journal of Clinical Epidemiology, 45, 743-60.

[18] Regan, J., Yarnold, J., Jones, P.W., and Cooke, N.T. (1991) Palliation and life quality in lung cancer: how good are clinicians at judging treatment outcome? British Journal of Cancer, 64, 396-400.

[19] Sneeuw, K.C.A., Aaronson, N.K., Osoba, D., Muller, M.J., Hsu, M-A., Yung, W.K.A., Brada, M., and Newlands, E.S. (1997) The use of significant others as proxy raters of the Quality of Life of patients with brain cancer. Medical Care, 35, 490-506.

[20] Cassileth, B.R., Lusk, E.J., and Tenaglia, A.N. (1982) A psychological comparison of patients with malignant melonomas and other dermatological diseases. Journal of the American Academy of Dermatology, 7, 742-6.

[21] Cassileth, B.R., Lusk, E.J., Strouse, T.B., Miller, D.S., Brown, L.L., Cross, P.A., and Tenaglia, A.N. (1984) Psychological status in chronic illness: a comparative analysis of six diagnostic groups. New England Journal of Medicine, 311, 506-11.

[22] Brickman, P., Coates, D., and Janoff-Bulman, R. (1978) Lottery winners and accident victims: is happiness relative? Journal of Personality and Social Psychology, 36, 917-27.

[23] Schneider, M. (1975) The quality of life in large American cities: objective and subjective social indicators. Social Indicators Research, 1, 495-509.

[24] Liu, D.C. (1973)The Quality ofLife in the United States: 1970. Kansas City, Mo, Midwest Research Institute.

[25] Easterlin, R. (1973) Does money buy happiness? The Public Interest (Winter), 30, 3-10.

[26] Cameron, P. (1972) Stereotypes about generational fun and happiness vs self-appraised fun and happiness. The Gerontologist (Summer), 12 (2, Pt 1), 120-3.

[27] Cameron, P., Titus, D.G., Kostin, J., and Kostin, M. (1973) The life satisfaction of non-normal persons. Journal of Counseling and Clinical Psychology, 41, 207-14.

[28] Visser, M.R.M., Smets, E.M.A., Sprangers, M.A.G., and de Haes, H.J.C.J.M. (2000) How response shift may affect the measurement of change in fatigue. Journal of Pain and Symptom Management, 20, 12-18.

[29] Fletcher, A. (1995) Quality oflife measurement in the evaluation oftreatment: proposed guidelines. British Journal of Clinical Pharmacology, 39, 217-22.

[30] Brinkley, D. (1985) Quality oflife in cancer trials. British Medical Journal, 291, 685-6.

[31] Slevin, M.L., Plant, H., Lynch, D., Drinkwater, J., and Gregory, W.M. (1988) Who should measure quality oflife, the doctor or the patient? British Journal of Cancer, 57, 109-12.

[32] Machin, D. (1996) Assessment of Quality ofLife in clinical trials of the British Medical Research Council. Journal of the National Cancer Institute Monographs, No 20.

[33] Young, T., de Haes, H., Curran, D., Fayers, P., and Brandenberg, Y. (1999) Guidelines for assessing Quality ofLife in EORTC clinical trials. EORTC.

[34] Fayers, P.M., Hopwood, P., Harvey, A., Girling, D.J., Machin, D., and Stephens, R. (1997) Quality ofLife assessment in clinical trials - Guidelines and a checklist for protocol writers: the UK Medical Research Council Experience. European Journal ofCancer, 33, 20-8.

[35] Scott, C.B., Stetz, J., Bruner, D.W., and Wasserman, T.H. (1994) Radiation Therapy Oncology Group Quality of Life assessment: design, analysis and data management issues. Quality ofLife Research, 3, 199-206.

[36] Groenvold, M., and Fayers, P.M. (1998) Testing for differences in multiple Quality ofLife dimensions: generating hypotheses from the experience of hospital staff. Quality ofLife Research, 7, 479-86.

[37] Sur, R.K., Kochhar, R., and Singh, D.P. (1994) Oral sucralfate in acute radiation oesophagitis. Acta Oncologica, 33, 61-3.

[38] Marty, M. on behalf ofthe Granisetron Study Group. (1992) A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. European Journal of Cancer, 28A(suppl 1), S12-6.

[39] Medical Research Council Lung Cancer Working Party. (1996) Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clinical Oncology, 8, 167-75.

[40] Moore, M.J., Osoba, D., Murphy, K., Tannock, I.F., Armitage, A., Findlay, B., Coppin, C., Neville, A., Venner, P., and Wilson, J. (1994) Use of palliative endpoints to evaluate the effects of mitoxantrone and low dose prednisone in patients with hormonally resistant prostate cancer. Journal of Clinical Oncology, 12, 689-94.

[41] Medical Research Council Lung Cancer Working Party. (1996) Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet, 348, 563-6.

[42] Burris, H., and Storniolo, A.M. (1997) Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. European Journal of Cancer, 33 (suppl 1), S18-22.

[43] Stephens, R.J., Hopwood, P., and Girling, D.J. (1999) Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise. British Journal of Cancer, 79, 538-44.

[44] Orr, S.T., and Aisner, J. (1986) Performance status assessment among oncology patients: a review. Cancer Treatment Reports, 70, 1423-9.

[45] Karnovsky, D.A., and Burchenal, J.H. (1949) The clinical evaluation of chemotherapeutic agents in cancer. In Macleod CM ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 191-205.

[46] Zubrod, C.G., Schneiderman, M., Frei, E., Brindley, C., Gold, L.G., and Schnider, B. (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal ofChronic Diseases, 11, 7-33.

[47] World Health Organization. (1948) WHO handbook for reporting results of cancer treatment. WHO offset publication No 48. World Health Organization.

[48] McHorney, C.A., Ware, J.E., Rogers, W., Raczek, A.E., and Lu, J.F.R. (1992) The validity and relative precision of MOS short- and long-form Health Status Scales and Dartmouth COOP charts. Medical Care, 30, MS253-5.

[49] Fayers, P.M., and Hand, D.J. (1997) Factor analysis, causal indicators and Quality of Life. Quality of Life Research, 6, 139-50.

[50] Fayers, P.M., Hand, D.J., Bjordal, K., and Groenvold, M. (1997) Causal indicators in Quality of Life research. Quality of Life Research, 6, 393-406.

[51] Priestman, T.J., and Baum, M. (1976) Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet, I, 899-901.

[52] Boyd, N.F., Selby, P.J., Sutherland, H.J., and Hogg, S. (1988) Measurement ofthe clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales. Journal of Clinical Epidemiology, 41, 243-50.

[53] Selby, P. (1985) Measurement ofthe quality of life after cancer treatment. British Journal of Hospital Medicine, 33, 266-71.

[54] Fayers, P.M. (1995) MRC Quality of Life studies using a daily diary card -practical lessons learned from cancer trials. Quality of Life Research, 4, 343-52.

[55] Bjordal, K., and Kaasa, S. (1992) Psychmetric validation of the EORTC core quality of life questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncologica, 31, 311-21.

[56] Ware, J.E., and Sherbourne, C.D. (1992) The MOS 36-item short-form health survey (SF-36). Medical Care, 30, 473-83.

[57] Hunt, S.M., McKenna, S.P., McEwen, J., Backett, E.M., Williams, J., andPapp, E. (1980) Aquantitative approach to perceived health status: a validation study. Journal ofEpidemiology and Community Health, 34, 281-6.

[58] Bergner, M., Bobbitt, R.A., Carter, W.B., and Gilson, B.S. (1981) The Sickness Impact Profile: development and final revision of a health status measure. Medical Care, 19, 787-805.

[59] Sackett, D.L., Chambers, L.W., MacPherson, A.S., Goldsmith, C.H., and McAuley, R.G. (1977) The development and application of indices of health: general methods and a summary of results. American Journal ofPublic Health, 67, 423-8.

[60] Chambers, L.W., Macdonald, L.A., Tugwell, P., Buchanan, W.W., and Kraag, G. (1982) The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. The Journal of Rheumatology, 5, 780-4.

[61] Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, H., Fleishman, S.B., de Haes, J.C.J.M., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P.B., Schraub, S., Sneeuw, K., Sullivan, M., and Takeda, F. (1993) The European Organization for

Research and Treatment of Cancer QLQ-C30: a Quality of Life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-76.

[62] Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S.B., Winicour, P., Brannon, J., Eckberg, K., Lloyd, S., Purl, S., Blendowski, C., Goodman, M., Barnicle, M., Stewart, I., McHale, M., Bonomi, P., Kaplan, E., Taylor, S., Thomas, C.R., and Harris, J. (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology, 11, 570-9.

[63] de Haes, J.C.J.M., van Knippenberg, F.C.E., and Neijt, J.P. (1990) Measuring psychological and physical distress in cancer patients: structure and application ofthe Rotterdam Symptom Checklist. British Journal of Cancer, 62, 1034-8.

[64] Schipper, H., Clinch, J., McMurray, A. and Levitt, M. (1984) Measuring the Quality of Life of cancer patients: the functional living index - cancer: development and validation. Journal of Clinical Oncology, 2, 472-83.

[65] Schag, C.C., Heinrich, R.L., Aadland, R., and Ganz, P.A. (1990) Assessing problems of cancer patients: psychometric properties ofthe cancer inventory of problem situations. Health Psychology, 9, 83-102.

[66] Schag, C.A.C., Ganz, P.A., and Heinrich, R.L. (1991) Cancer Rehabilitation Evaluation System -Short Form (CARES-SF). Cancer, 68, 1406-13.

[67] Levine, M.N., Guyatt, G.H., Gent, M., de Pauw, S., Goodyear, M.D., Hryniuk, W.M., Arnold, A., Findlay, B., Skillings, J.R., Bramwell, V.H., Levin, L., Bush, H., Abu-Zahra, H., and Kotalik, J. (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. Journal of Clinical Oncology, 6, 1798-810.

[68] Zigmond, A.S., and Snaith, R.P. (1983) The Hospital Anxiety and Depression scale. Acta Psychiatrica Scandinavica, 67, 361-70.

[69] Kind, P. (1996) The EuroQoL instrument: an index of health-related quality of life. In: Spilker, B., Quality of Life and Pharmacoeconomics in Clinical Trials, Philadelphia: Lippincott-Raven.

[70] Fraser, S.C.A., Ramirez, A.J., Ebbs, S.R., Fallowfield, L.J., Dobbs, H.J., Richards, M.A., Bates, T. and Baum, M. (1993) A daily diary for quality of life measurement in advanced breast cancer trials. British Journal of Cancer, 67, 341-6.

[71] Testa, M.A., and Simonson, D.C. (1996) Assessment of quality of life outcomes. New England Journal of Medicine, 334, 835-40.

[72] Kemmler, G., Holzner, B., Kopp, M., Dunser, M., Margreiter, R., Greil, R., and Sperner-Unterweger, B. (1999) Comparison of two quality of life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Journal of Clinical Oncology, 17, 2932-40.

[73] King, M.T., Dobson, A.J., and Harnett, P.R. (1996) A comparison of two quality of life questionnaires for cancer clinical trials: the functional living index-cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). Journal of Clinical Epidemiology, 49, 21-9.

[74] Hollen, P.J., and Gralla, R.J. (1996) Comparison of instruments for measuring quality of life in patients with lung cancer. Seminars in Oncology, 23, 2(suppl 5), 31-40.

[75] Weinberger, M., Oddone, E.Z., Samsa, G.P., and Landsman, P.B. (1996) Are health-related quality of life measures affected by the mode of administration? Journal of Clinical Epidemiology, 49, 135-40.

[76] Ganz, P.A., Haskell, C.M., Figlin, R.A., La Soto, N. and Siau, J. (1988) Estimating the Quality of Life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index - Cancer. Cancer, 61, 849-56.

[77] Finkelstein, D.M., Cassileth, B.R., Bonomi, P.D., Ruckdeschel, J.C., Ezdinli, E.Z., and Wolter, J.M. (1988) A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. American Journal of Clinical Oncology, 11, 630-3.

[78] Hurny, C., Bernhard, J., Joss, R., Willems, Y., Cavalli, F., Kiser, J., Brunner, K., Favre, S., Alberto, P., Glaus, A., Senn, H., Schatzmann, E., Ganz, P.A., and Metzger, U. (1992) Feasibility of Quality of Life assessment in a randomized phase III trial of small cell lung cancer. Annals of Oncology, 3, 825-31.

[79] Giaccone, G., Splinter, T.A.W., Debruyne, C., Kho, G.S., Lianes, P., van Zandwijk, N., Pennucci, M.C., Scagliotti, G., van Meerbeeck, J., van Hoesel, Q., Curran, D., Sahmoud, T., and Postmus, P.E. (1998) Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small cell lung cancer. Journal of Clinical Oncology, 16, 2133-41.

[80] Langendijk, J.A., ten Velde, G.P.M., Aaronson, N.K., de Jong, J.M.A., Muller, M.J., and Wouters, E.F.M. (2000) Quality of life after palliaitve radiotherapy in non-small cell lung cancer: aprospective study. International Journal of Radiation Oncology Biology and Physics, 47, 149-55.

[81] Wisloff, F., Eika, S., Hippe, E., Hjorth, M., Homberg, E., Kaasa, S., Palva, I., and Westin, J. (1996) Measurement of health-related quality of life in multiple myeloma. British Journal ofHaematology, 92, 604-13.

[82] Sadura, A., Pater, J., Osoba, D., Levine, M., Palmer, M., and Bennett, K. (1992) Quality of life assessment: patient compliance with questionnaire completion. Journal of the National Cancer Institute, 84, 1023-6.

[83] Ganz, P.A., Moinpour, C.M., Cella, D.F., and Fetting, J.H. (1992) Quality of life assessment in cancer clinical trials: a status report. Journal of the National Cancer Institute, 84, 994-5.

[84] Moinpour, C.M., Feigl, P., Metch, B., Hayden, K.A., Meyskens, F.L., and Crowley, J. (1989) Quality of Life endpoints in cancer clinical trials: review and recommendations. Journal of the National Cancer Institute, 81, 485-95.

[85] Cox, D.R., Fitzpatrick, R., Fletcher, A.E., Gore, S.M., Spiegelhalter, D.J., and Jones, D.R. (1992) Quality of life assessment: canwekeep it simple? Journal of the Royal Statistical Society, 155, 353-93.

[86] Brorsson, B., Ifver, J., and Hays, R.D. (1993) The Swedish health-related quality of life survey (SWED-QUAL). Quality of Life Research, 2, 33-45.

[87] Hopwood, P., Harvey, A., Davies, J., Stephens, R.J., Girling, D.J., Gibson, D., and Parmar, M.K.B. (1997) Survey of the administration of Quality of Life (QL) questionnaires in three multicentre randomised trials in cancer. European Journal of Cancer, 34, 49-57.

[88] Testa, M.A., Hollenberg, N.K., Anderson, R.B., and Williams, G.H. (1991) Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. American Journal of Hypertension, 4, 363-73.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment